RxDoctor Payments Data

Gregory Bryan, DPM

Foot Surgery · Shreveport, LANPI 1528035888

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,064 of the $3,548 with a category attached, or 86.4%. It is spread thinly across 27 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $833 and has fallen 56.3% since, to $364 in 2025.

$3,548in general payments, 2019–2025

Across 110 payments — averaging $32.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paratek Pharmaceuticals, Inc.$514
  • Treace Medical Concepts, Inc.$484
  • Melinta Therapeutics, LLC$299
  • Stryker$265
  • Heron Therapeutics, Inc.$232
  • Organogenesis Inc.$219
  • plus $2K from 21 others

What the payments were for

  • Travel & lodging$48414%
  • Food & beverage$3,06486%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few foot surgery providers in Louisianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$267,001
Medicare patients
472
Services billed
2,498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin11$4,255
Betamethasone Dipropionate22$1,014
Fluconazole23$981
Terbinafine Hcl40$715
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen59$448
Amitriptyline Hcl23$308
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$122
Prednisone26$41
Azithromycin11$33

Paid to pharmacies, not to this prescriber.

Other foot surgery in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →